Skip to main content
Research Use Only 57-Product Catalog Flexible Order Quantities Batch-Document Support U.S. Fulfilment for Selected Stock Tracked Shipping Options Custom Synthesis & OEM Research Use Only 57-Product Catalog Flexible Order Quantities Batch-Document Support U.S. Fulfilment for Selected Stock Tracked Shipping Options Custom Synthesis & OEM
Home/Products/CJC-1295 With DAC

Material & batch records

CJC-1295 With DAC

Compare the material specification with the scope of the available records.

CJC-1295 With DAC — existing catalog illustration
Existing catalog illustration. A pictured label is not a batch result and may differ from the selected specification.

Modified GHRH analogue / Material & batch records

Modified GHRH analogue
Specification & documents

CJC-1295 with DAC denotes a modified GHRH-related peptide carrying a drug-affinity-complex feature.

MATERIALCJC-1295 With DAC
SPECIFICATION1 catalog option
DOCUMENT SCOPEConfirm the offered lot
USELaboratory research only
Catalog specification — select for your inquiry

Selected: 5 mg × 10 vials

Nominal catalog options, not a live availability guarantee. Final supply is confirmed in the written quotation.

Evidence for the offered material

Batch records

No matching public batch attachment was found on this product page during this catalog review. Request the documents for the offered lot; this does not mean no testing exists.

Identity

Ask for the DAC modification and attachment specification along with the sequence. Confirm whether analytical identity testing distinguishes the requested form.

Analytical scope

Ask which tests and underlying files are available, what each result measures and which batch it covers. Do not infer a test result from an image or badge.

Order match

Match product name, selected specification, lot reference and packaging to the quotation. Ask about any difference before confirming supply.

Material profile

Material identity

CJC-1295 with DAC denotes a modified GHRH-related peptide carrying a drug-affinity-complex feature.

For CJC-1295 With DAC, a document is useful only when its sample description matches the requested material. This page keeps reference identity, catalog quantities and batch-document scope separate.

The key distinction
Ask for the DAC modification and attachment specification along with the sequence. Confirm whether analytical identity testing distinguishes the requested form.

Catalog & quotation

Catalog specification

Catalog materialCJC-1295 With DAC
Material classModified GHRH analogue
Listed options5 mg × 10 vials
Catalog reference CAS446262-90-4Reference field only; confirm it matches the supplied form.
Catalog reference formulaC165H269N47O46Reference field only; confirm it matches the supplied form.
Catalog reference molecular weight3647.2 g/molReference field only; confirm it matches the supplied form.
Identity / supplied formAsk for the DAC modification and attachment specification along with the sequence. Confirm whether analytical identity testing distinguishes the requested form.
Identity, purity and contentRequest the method, acceptance specification and lot-specific results. Chromatographic purity and net material content are separate measurements.
Storage / stabilityFollow the written instructions for the actual material and batch. No universal 24-month shelf life or solution stability is assumed.
Catalog options are inquiry specifications, not a live stock feed. The final quotation must confirm the material, amount, packaging and document scope.

Scientific context

Research background

The conjugation-related modification is central to the research identity. A without-DAC analogue is not the same material even if both names contain CJC-1295.

01

Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.

Drug testing and analysis · 2010 · PMID 21204297

Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.

Read the primary publication ↗
02

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.

Endocrinology · 2005 · PMID 15817669

Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.

Read the primary publication ↗

For laboratory research use only. Not for human or veterinary use, diagnosis or therapeutic application. No administration or dosing protocol is provided.

Before you inquire

Document questions

What needs to be confirmed about the DAC modification?

Ask for the DAC modification and attachment specification along with the sequence. Confirm whether analytical identity testing distinguishes the requested form.

What should my CJC-1295 With DAC inquiry include?

Include the exact material name, the catalog option or required specification, quantity, destination and any documents needed before quotation. Keep nominal amount per container separate from the number of containers.

Does the catalog image confirm the selected specification?

No. It is a catalog illustration. The image may show one variant while the selector lists other options. Use the written quotation and matching batch documents to confirm supply.

Does a paper or an existing report validate every future batch?

No. A paper describes its studied material and model. An analytical report describes a named sample. Confirm the connection between any report and the lot offered for your order.

Catalog content reviewed 26 September 2026. Listed options are from this site's product records. Scientific sources, where shown, describe research context, not batch certification.

Connect the material to the document.

Include the material, amount and evidence your laboratory needs to review.

Prepare an inquiry